华邦健康: 2025年半年度报告摘要

Core Viewpoint - The report highlights the financial performance of Huabong Life Health Co., Ltd. for the first half of 2025, showing an increase in revenue and net profit compared to the same period last year. Financial Performance - Operating revenue for the reporting period reached CNY 5,945,032,088.09, a slight increase of 0.39% from CNY 5,922,042,354.85 in the previous year [1]. - Net profit attributable to shareholders was CNY 388,455,625.50, representing a significant increase of 23.90% from CNY 313,522,665.65 [1]. - The net profit after deducting non-recurring gains and losses was also reported, but specific figures were not provided [1]. - The net cash flow from operating activities increased by 46.10% to CNY 536,502,508.00 from CNY 367,219,592.32 [1]. - Basic and diluted earnings per share rose to CNY 0.1969, up 24.15% from CNY 0.1586 [1]. Asset and Equity Position - Total assets at the end of the reporting period were CNY 29,654,478,331.32, a 0.69% increase from CNY 29,450,469,334.61 at the end of the previous year [2]. - Net assets attributable to shareholders increased by 4.41% to CNY 9,748,372,423.62 from CNY 9,337,058,173.60 [2]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 73,829 [2]. - The largest shareholder, Chongqing Huabong Zhuoyuan Technology Co., Ltd., holds 18.71% of the shares [2]. - The report indicates that there were no changes in the controlling shareholder or actual controller during the reporting period [6]. Debt and Financial Ratios - The debt-to-asset ratio at the end of the reporting period was 46.17%, down from 47.46% [4]. - The EBITDA interest coverage ratio improved to 9.17 from 7.07 in the previous year [4].